Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for ARQT

Stock Name	Arcutis Biotherapeutics Inc
Ticker	ARQT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US03969K1088

Show aggregate ARQT holdings

News associated with ARQT

Zurcher Kantonalbank Zurich Cantonalbank Raises Stock Position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 3.2% in the first quarter, HoldingsChannel reports. The institutional investor owned 29,697 shares of the company’s stock after purchasing an additional 917 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Arcutis Biotherapeutics were worth $464,000 at the […] - 2025-08-08 04:56:49
Arcutis Biotherapeutics (NASDAQ:ARQT) Coverage Initiated at The Goldman Sachs Group: The Goldman Sachs Group began coverage on shares of Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) in a research report released on Friday, MarketBeat.com reports. The brokerage issued a neutral rating and a $18.00 price target on the stock. A number of other brokerages have also commented on ARQT. Needham & Company LLC reiterated a “buy” […] - 2025-07-28 02:05:01
Patrick Burnett Sells 23,000 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Stock: Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) insider Patrick Burnett sold 23,000 shares of the company’s stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $15.05, for a total value of $346,150.00. Following the sale, the insider owned 115,468 shares of the company’s stock, valued at […] - 2025-07-16 05:29:11
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Receives Consensus Recommendation of “Moderate Buy” from Analysts: Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) have received an average recommendation of “Moderate Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price […] - 2025-07-10 05:48:58
SG Americas Securities LLC Has $509,000 Stock Position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): SG Americas Securities LLC lowered its holdings in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 32.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 32,566 shares of the company’s stock after selling 15,521 shares during the period. SG Americas Securities […] - 2025-06-23 04:29:10
Wealth Enhancement Advisory Services LLC Purchases Shares of 20,912 Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 20,912 shares of the company’s stock, valued at approximately $291,000. Other hedge funds and other institutional investors have also bought and sold shares of the […] - 2025-06-16 04:08:49
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 1.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 280,100 shares of the company’s stock […] - 2025-06-05 05:16:57
Analysts Anticipate 25% Gains Ahead For The Holdings of FHLC: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-29 08:03:59
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Shares Sold by Deutsche Bank AG: Deutsche Bank AG lessened its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 51.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 387,536 shares of the company’s stock after selling 412,491 shares during the quarter. Deutsche Bank AG’s holdings […] - 2025-05-19 05:07:00
Northern Trust Corp Purchases 54,541 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Northern Trust Corp increased its position in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 5.8% during the fourth quarter, HoldingsChannel reports. The fund owned 991,056 shares of the company’s stock after buying an additional 54,541 shares during the quarter. Northern Trust Corp’s holdings in Arcutis Biotherapeutics were worth $13,805,000 at the end […] - 2025-05-16 04:22:56
Schonfeld Strategic Advisors LLC Sells 7,349 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Schonfeld Strategic Advisors LLC lessened its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 24.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 23,000 shares of the company’s stock after selling 7,349 shares during the quarter. Schonfeld Strategic Advisors […] - 2025-05-13 06:15:01
Price T Rowe Associates Inc. MD Reduces Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Price T Rowe Associates Inc. MD decreased its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 29.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 42,349 shares of the company’s stock after selling 17,799 shares during the […] - 2025-05-13 04:32:49
Voya Investment Management LLC Sells 2,472 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Voya Investment Management LLC trimmed its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 7.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 32,136 shares of the company’s stock after selling 2,472 shares during the period. Voya Investment […] - 2025-05-11 05:44:48
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Stock Position Boosted by Tower Research Capital LLC TRC: Tower Research Capital LLC TRC grew its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 62.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,231 shares of the company’s stock after buying an additional 5,488 shares during the quarter. […] - 2025-05-06 05:09:04
Wells Fargo & Company MN Has $731,000 Stock Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Wells Fargo & Company MN increased its holdings in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 46.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 52,455 shares of the company’s stock after purchasing an additional 16,682 shares during the quarter. Wells Fargo & Company MN’s holdings in Arcutis Biotherapeutics were […] - 2025-05-02 04:18:56
Geode Capital Management LLC Increases Stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Geode Capital Management LLC boosted its stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 0.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 2,472,730 shares of the company’s stock after buying an additional 2,592 shares during the quarter. Geode Capital Management LLC’s holdings in Arcutis Biotherapeutics were worth $34,453,000 as of […] - 2025-04-17 05:18:49
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Shares Sold by Wellington Management Group LLP: Wellington Management Group LLP lowered its stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 7.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 49,267 shares of the company’s stock after selling 3,882 shares during the quarter. Wellington Management Group LLP’s holdings in Arcutis Biotherapeutics […] - 2025-04-15 04:46:50
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Shares Sold by CIBC Private Wealth Group LLC: CIBC Private Wealth Group LLC reduced its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 18.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 7,782 shares of the company’s stock after selling 1,776 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in Arcutis […] - 2025-04-08 06:03:20
Teacher Retirement System of Texas Boosts Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Teacher Retirement System of Texas grew its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 19.5% during the 4th quarter, HoldingsChannel reports. The fund owned 31,216 shares of the company’s stock after purchasing an additional 5,087 shares during the period. Teacher Retirement System of Texas’ holdings in Arcutis Biotherapeutics were worth $435,000 at […] - 2025-04-01 04:40:45
Intech Investment Management LLC Buys 5,168 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Intech Investment Management LLC boosted its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 13.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 42,258 shares of the company’s stock after acquiring an additional 5,168 shares during the period. Intech Investment Management LLC’s holdings in Arcutis Biotherapeutics were worth $589,000 […] - 2025-03-25 06:29:08
AlphaQuest LLC Decreases Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): AlphaQuest LLC lessened its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 83.3% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 7,142 shares of the company’s stock after selling 35,696 shares during the quarter. AlphaQuest LLC’s holdings in Arcutis Biotherapeutics were worth $99,000 as of its most recent filing […] - 2025-03-19 06:10:46
Bank of New York Mellon Corp Cuts Stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Bank of New York Mellon Corp decreased its stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 1.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 305,007 shares of the company’s stock after selling 6,052 shares during the period. Bank […] - 2025-03-19 05:08:45
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says: Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) had its price target lifted by Jefferies Financial Group from $16.00 to $19.00 in a research report report published on Tuesday,Benzinga reports. The firm currently has a buy rating on the stock. Other research analysts have also issued research reports about the company. HC Wainwright reiterated a “buy” rating […] - 2025-03-12 04:56:51
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Expected to Rise, Mizuho Analyst Says: Arcutis Biotherapeutics (NASDAQ:ARQT – Get Free Report) had its target price lifted by stock analysts at Mizuho from $20.00 to $21.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Mizuho’s target price suggests a potential upside of 64.06% from the stock’s previous close. A number of […] - 2025-02-28 04:52:44

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) ARQT holdings

Date	Number of ARQT Shares Held	Base Market Value of ARQT Shares	Local Market Value of ARQT Shares	Change in ARQT Shares Held	Change in ARQT Base Value	Current Price per ARQT Share Held	Previous Price per ARQT Share Held
2025-11-11 (Tuesday)	76,947	USD 1,849,036	USD 1,849,036	0	USD 21,545	USD 24.03	USD 23.75
2025-11-10 (Monday)	76,947	USD 1,827,491	USD 1,827,491	197	USD -32,162	USD 23.75	USD 24.23
2025-11-07 (Friday)	76,750	USD 1,859,653	USD 1,859,653	0	USD -66,772	USD 24.23	USD 25.1
2025-11-06 (Thursday)	76,750	USD 1,926,425	USD 1,926,425	197	USD 60,063	USD 25.1	USD 24.38
2025-11-05 (Wednesday)	76,553	USD 1,866,362	USD 1,866,362	0	USD 28,324	USD 24.38	USD 24.01
2025-11-04 (Tuesday)	76,553	USD 1,838,038	USD 1,838,038	198	USD -52,512	USD 24.01	USD 24.76
2025-11-03 (Monday)	76,355	USD 1,890,550	USD 1,890,550	0	USD -41,995	USD 24.76	USD 25.31
2025-10-31 (Friday)	76,355	USD 1,932,545	USD 1,932,545	0	USD 29,778	USD 25.31	USD 24.92
2025-10-30 (Thursday)	76,355	USD 1,902,767	USD 1,902,767	990	USD -3,214	USD 24.92	USD 25.29
2025-10-29 (Wednesday)	75,365	USD 1,905,981	USD 1,905,981	396	USD 35,504	USD 25.29	USD 24.95
2025-10-28 (Tuesday)	74,969	USD 1,870,477	USD 1,870,477	0	USD 398,086	USD 24.95	USD 19.64
2025-10-27 (Monday)	74,969	USD 1,472,391	USD 1,472,391	0	USD -35,236	USD 19.64	USD 20.11

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ARQT by Blackrock for IE00BDZVHG35

Show aggregate share trades of ARQT

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 197 24.860 23.740 23.852 USD 4,699 14.48
2025-11-06 BUY 197 25.350 23.770 23.928 USD 4,714 14.37
2025-11-04 BUY 198 24.560 23.850 23.921 USD 4,736 14.26
2025-10-30 BUY 990 27.079 24.770 25.001 USD 24,751 14.08
2025-10-29 BUY 396 25.290 25.990 25.920 USD 10,264 14.02
2025-10-22 SELL -792 19.810 20.730 20.638 USD -16,345 13.82 Loss of -5,401 on sale
2025-10-20 BUY 396 20.880 21.200 21.168 USD 8,383 13.74
2025-10-17 BUY 989 20.880 21.085 21.064 USD 20,833 13.70
2025-10-15 BUY 1,576 21.630 21.715 21.707 USD 34,209 13.65
2025-10-03 BUY 1,386 19.920 21.300 21.162 USD 29,331 13.57
2025-10-02 BUY 198 21.250 21.290 21.286 USD 4,215 13.52
2025-09-30 BUY 396 18.850 19.360 19.309 USD 7,646 13.45
2025-09-26 BUY 396 17.570 17.695 17.682 USD 7,002 13.40
2025-09-25 BUY 396 16.730 17.349 17.287 USD 6,846 13.38
2025-09-18 BUY 207 17.710 17.880 17.863 USD 3,698 13.35
2025-09-17 BUY 624 17.140 17.800 17.734 USD 11,066 13.32
2025-07-17 SELL -412 15.480 15.575 15.565 USD -6,413 13.27 Loss of -945 on sale
2025-07-11 SELL -1,656 15.010 15.300 15.271 USD -25,289 13.21 Loss of -3,406 on sale
2025-07-02 BUY 11,385 13.760 13.980 13.958 USD 158,912 13.19
2025-06-25 BUY 414 14.470 14.648 14.630 USD 6,057 13.16
2025-06-20 BUY 1,996 13.820 14.300 14.252 USD 28,447 13.14
2025-06-11 BUY 402 13.730 14.420 14.351 USD 5,769 13.12
2025-06-10 BUY 402 13.890 14.410 14.358 USD 5,772 13.11
2025-06-04 SELL -201 13.270 13.470 13.450 USD -2,703 13.09 Loss of -73 on sale
2025-04-23 BUY 200 14.450 15.020 14.963 USD 2,993 12.77
2025-04-10 SELL -1,600 13.440 13.870 13.827 USD -22,123 12.73 Loss of -1,752 on sale
2025-04-08 SELL -200 13.290 15.180 14.991 USD -2,998 12.70 Loss of -457 on sale
2025-04-07 SELL -200 14.300 15.000 14.930 USD -2,986 12.69 Loss of -449 on sale
2025-04-04 SELL -1,000 14.730 16.040 15.909 USD -15,909 12.66 Loss of -3,247 on sale
2025-04-01 BUY 2,273 14.980 15.570 15.511 USD 35,257 12.59
2025-03-31 SELL -588 15.640 16.110 16.063 USD -9,445 12.55 Loss of -2,066 on sale
2025-03-21 BUY 3,310 17.010 17.120 17.109 USD 56,631 12.23
2025-03-14 SELL -2,976 14.620 15.380 15.304 USD -45,545 11.96 Loss of -9,957 on sale
2025-03-07 SELL -370 14.720 14.860 14.846 USD -5,493 11.73 Loss of -1,151 on sale
2025-03-04 SELL -186 13.400 14.000 13.940 USD -2,593 11.62 Loss of -432 on sale
2025-02-25 BUY 372 12.200 12.600 12.560 USD 4,672 11.50
2025-02-19 SELL -185 12.990 13.230 13.206 USD -2,443 11.39 Loss of -335 on sale
2025-02-13 BUY 555 12.310 13.220 13.129 USD 7,287 11.30
2025-02-12 BUY 185 13.210 13.880 13.813 USD 2,555 11.26
2025-02-11 BUY 740 11.400 11.485 11.476 USD 8,493 11.26
2024-12-30 SELL -5,766 14.200 14.641 14.597 USD -84,166 10.32 Loss of -24,648 on sale
2024-11-18 SELL -3,000 9.430 9.460 9.457 USD -28,371 9.00 Loss of -1,356 on sale
2024-11-08 SELL -200 10.820 11.440 11.378 USD -2,276 8.79 Loss of -518 on sale
2024-10-21 SELL -202 8.310 8.810 8.760 USD -1,770 0.00 Loss of -1,770 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	197	24.860	23.740	23.852	USD 4,699	14.48
2025-11-06	BUY	197	25.350	23.770	23.928	USD 4,714	14.37
2025-11-04	BUY	198	24.560	23.850	23.921	USD 4,736	14.26
2025-10-30	BUY	990	27.079	24.770	25.001	USD 24,751	14.08
2025-10-29	BUY	396	25.290	25.990	25.920	USD 10,264	14.02
2025-10-22	SELL	-792	19.810	20.730	20.638	USD -16,345	13.82 Loss of -5,401 on sale
2025-10-20	BUY	396	20.880	21.200	21.168	USD 8,383	13.74
2025-10-17	BUY	989	20.880	21.085	21.064	USD 20,833	13.70
2025-10-15	BUY	1,576	21.630	21.715	21.707	USD 34,209	13.65
2025-10-03	BUY	1,386	19.920	21.300	21.162	USD 29,331	13.57
2025-10-02	BUY	198	21.250	21.290	21.286	USD 4,215	13.52
2025-09-30	BUY	396	18.850	19.360	19.309	USD 7,646	13.45
2025-09-26	BUY	396	17.570	17.695	17.682	USD 7,002	13.40
2025-09-25	BUY	396	16.730	17.349	17.287	USD 6,846	13.38
2025-09-18	BUY	207	17.710	17.880	17.863	USD 3,698	13.35
2025-09-17	BUY	624	17.140	17.800	17.734	USD 11,066	13.32
2025-07-17	SELL	-412	15.480	15.575	15.565	USD -6,413	13.27 Loss of -945 on sale
2025-07-11	SELL	-1,656	15.010	15.300	15.271	USD -25,289	13.21 Loss of -3,406 on sale
2025-07-02	BUY	11,385	13.760	13.980	13.958	USD 158,912	13.19
2025-06-25	BUY	414	14.470	14.648	14.630	USD 6,057	13.16
2025-06-20	BUY	1,996	13.820	14.300	14.252	USD 28,447	13.14
2025-06-11	BUY	402	13.730	14.420	14.351	USD 5,769	13.12
2025-06-10	BUY	402	13.890	14.410	14.358	USD 5,772	13.11
2025-06-04	SELL	-201	13.270	13.470	13.450	USD -2,703	13.09 Loss of -73 on sale
2025-04-23	BUY	200	14.450	15.020	14.963	USD 2,993	12.77
2025-04-10	SELL	-1,600	13.440	13.870	13.827	USD -22,123	12.73 Loss of -1,752 on sale
2025-04-08	SELL	-200	13.290	15.180	14.991	USD -2,998	12.70 Loss of -457 on sale
2025-04-07	SELL	-200	14.300	15.000	14.930	USD -2,986	12.69 Loss of -449 on sale
2025-04-04	SELL	-1,000	14.730	16.040	15.909	USD -15,909	12.66 Loss of -3,247 on sale
2025-04-01	BUY	2,273	14.980	15.570	15.511	USD 35,257	12.59
2025-03-31	SELL	-588	15.640	16.110	16.063	USD -9,445	12.55 Loss of -2,066 on sale
2025-03-21	BUY	3,310	17.010	17.120	17.109	USD 56,631	12.23
2025-03-14	SELL	-2,976	14.620	15.380	15.304	USD -45,545	11.96 Loss of -9,957 on sale
2025-03-07	SELL	-370	14.720	14.860	14.846	USD -5,493	11.73 Loss of -1,151 on sale
2025-03-04	SELL	-186	13.400	14.000	13.940	USD -2,593	11.62 Loss of -432 on sale
2025-02-25	BUY	372	12.200	12.600	12.560	USD 4,672	11.50
2025-02-19	SELL	-185	12.990	13.230	13.206	USD -2,443	11.39 Loss of -335 on sale
2025-02-13	BUY	555	12.310	13.220	13.129	USD 7,287	11.30
2025-02-12	BUY	185	13.210	13.880	13.813	USD 2,555	11.26
2025-02-11	BUY	740	11.400	11.485	11.476	USD 8,493	11.26
2024-12-30	SELL	-5,766	14.200	14.641	14.597	USD -84,166	10.32 Loss of -24,648 on sale
2024-11-18	SELL	-3,000	9.430	9.460	9.457	USD -28,371	9.00 Loss of -1,356 on sale
2024-11-08	SELL	-200	10.820	11.440	11.378	USD -2,276	8.79 Loss of -518 on sale
2024-10-21	SELL	-202	8.310	8.810	8.760	USD -1,770	0.00 Loss of -1,770 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ARQT

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	341,726	35,090	772,423	44.2%
2025-09-18	165,661	1,522	363,887	45.5%
2025-09-17	284,725	0	630,736	45.1%
2025-09-16	179,844	22	395,466	45.5%
2025-09-15	175,552	0	491,917	35.7%
2025-09-12	307,525	0	657,235	46.8%
2025-09-11	258,316	280	539,943	47.8%
2025-09-10	437,027	1,316	950,925	46.0%
2025-09-09	532,770	0	1,150,718	46.3%
2025-09-08	452,889	5,712	986,459	45.9%
2025-09-05	361,617	50	1,130,359	32.0%
2025-09-04	366,561	100	1,012,477	36.2%
2025-09-03	292,438	175	835,684	35.0%
2025-09-02	228,380	100	443,104	51.5%
2025-08-29	226,806	1,350	420,494	53.9%
2025-08-28	256,315	377	611,736	41.9%
2025-08-27	144,101	0	315,281	45.7%
2025-08-26	209,333	0	530,210	39.5%
2025-08-25	180,217	50	442,972	40.7%
2025-08-22	147,996	0	373,958	39.6%
2025-08-21	89,117	0	274,940	32.4%
2025-08-20	175,749	54	518,920	33.9%
2025-08-19	86,602	0	356,660	24.3%
2025-08-18	152,543	34,957	607,121	25.1%
2025-08-15	136,335	0	738,567	18.5%
2025-08-14	196,629	0	845,242	23.3%
2025-08-13	166,144	452	1,181,490	14.1%
2025-08-12	146,797	0	602,664	24.4%
2025-08-11	270,539	384	620,441	43.6%
2025-08-08	386,298	25,035	1,202,815	32.1%
2025-08-07	1,109,375	22,631	1,675,042	66.2%
2025-08-06	341,028	1,278	574,755	59.3%
2025-08-05	223,064	170	693,798	32.2%
2025-08-04	217,706	41	446,616	48.7%
2025-08-01	401,671	3,150	744,554	53.9%
2025-07-31	177,568	572	398,666	44.5%
2025-07-30	265,582	600	669,791	39.7%
2025-07-29	251,383	2,815	615,844	40.8%
2025-07-28	302,393	0	690,493	43.8%
2025-07-25	450,530	0	755,422	59.6%
2025-07-24	186,949	515	400,240	46.7%
2025-07-23	169,528	0	376,358	45.0%
2025-07-22	284,845	0	536,876	53.1%
2025-07-21	278,122	570	433,724	64.1%
2025-07-18	282,650	0	669,379	42.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE